IQVIA beats Q1 revenue estimates, raises 2026 adj. EPS outlook

IQVIA Holdings

05/05/2026 12:10

Overview

US clinical research and healthcare data firm's Q1 revenue rose 8.4%, beating analyst expectations

Adjusted diluted EPS for Q1 beat analyst expectations

Company repurchased $552 mln of common stock in Q1

Outlook

IQVIA reaffirms 2026 revenue guidance of $17.15 bln to $17.35 bln

Company maintains 2026 adjusted EBITDA guidance of $3.98 bln to $4.03 bln

IQVIA raises 2026 adjusted diluted EPS guidance to $12.65-$12.95

Result Drivers

COMMERCIAL SOLUTIONS GROWTH - Co said Commercial Solutions segment delivered better-than-expected organic revenue growth, led by patient solutions, analytics & consulting, and commercial engagement services, with AI-enabled offerings gaining traction

R&D SOLUTIONS DEMAND - Co said R&D Solutions segment delivered better-than-expected organic revenue growth and solid growth in net service fee bookings, with mid-to-high single digit growth in forward-looking demand indicators

Company press release: ID:nBwbsDdR5a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$4.15 bln
$4.10 bln (18 Analysts)
Q1 Adjusted EPS
Beat
$2.90
$2.82 (20 Analysts)
Q1 EPS
$1.61


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 24 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the biotechnology & medical research peer group is "buy"

Wall Street's median 12-month price target for IQVIA Holdings Inc is $235.00, about 46% above its May 4 closing price of $160.94

The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 18 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)